Conjugated Linoleic Acid and Atherosclerosis

PHASE3CompletedINTERVENTIONAL
Enrollment

401

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Atherosclerosis
Interventions
DIETARY_SUPPLEMENT

oil rich in cis9, trans11 conjugated linoleic acid

An oil rich in cis9, trans11 conjugated linoleic acid (cis9,trans11-CLA). Of the total amount of CLA in the oil, 80% is cis9, trans11-CLA and 20% trans10, cis12-CLA. In total 4 grams of oil will be given daily. The oil will be taken in the form of soft gel capsules. Two capsules will be taken in the morning and two in the evening.

DIETARY_SUPPLEMENT

placebo

identical placebo capsules.

Trial Locations (1)

3584 CX

Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Aberdeen

OTHER

collaborator

Lipid Nutrition B.V

UNKNOWN

collaborator

Center Novem

UNKNOWN

lead

UMC Utrecht

OTHER

NCT00706745 - Conjugated Linoleic Acid and Atherosclerosis | Biotech Hunter | Biotech Hunter